Cargando…

Divergence in chondrogenic potential between in vitro and in vivo of adipose- and synovial-stem cells from mouse and human

BACKGROUND: Somatic stem cell transplantation has been performed for cartilage injury, but the reparative mechanisms are still conflicting. The chondrogenic potential of stem cells are thought as promising features for cartilage therapy; however, the correlation between their potential for chondroge...

Descripción completa

Detalles Bibliográficos
Autores principales: Chijimatsu, Ryota, Miwa, Satoshi, Okamura, Gensuke, Miyahara, Junya, Tachibana, Naohiro, Ishikura, Hisatoshi, Higuchi, Junya, Maenohara, Yuji, Tsuji, Shinsaku, Sameshima, Shin, Takagi, Kentaro, Nakazato, Keiu, Kawaguchi, Kohei, Yamagami, Ryota, Inui, Hiroshi, Taketomi, Shuji, Tanaka, Sakae, Saito, Taku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281654/
https://www.ncbi.nlm.nih.gov/pubmed/34266496
http://dx.doi.org/10.1186/s13287-021-02485-5
_version_ 1783722869812887552
author Chijimatsu, Ryota
Miwa, Satoshi
Okamura, Gensuke
Miyahara, Junya
Tachibana, Naohiro
Ishikura, Hisatoshi
Higuchi, Junya
Maenohara, Yuji
Tsuji, Shinsaku
Sameshima, Shin
Takagi, Kentaro
Nakazato, Keiu
Kawaguchi, Kohei
Yamagami, Ryota
Inui, Hiroshi
Taketomi, Shuji
Tanaka, Sakae
Saito, Taku
author_facet Chijimatsu, Ryota
Miwa, Satoshi
Okamura, Gensuke
Miyahara, Junya
Tachibana, Naohiro
Ishikura, Hisatoshi
Higuchi, Junya
Maenohara, Yuji
Tsuji, Shinsaku
Sameshima, Shin
Takagi, Kentaro
Nakazato, Keiu
Kawaguchi, Kohei
Yamagami, Ryota
Inui, Hiroshi
Taketomi, Shuji
Tanaka, Sakae
Saito, Taku
author_sort Chijimatsu, Ryota
collection PubMed
description BACKGROUND: Somatic stem cell transplantation has been performed for cartilage injury, but the reparative mechanisms are still conflicting. The chondrogenic potential of stem cells are thought as promising features for cartilage therapy; however, the correlation between their potential for chondrogenesis in vitro and in vivo remains undefined. The purpose of this study was to investigate the intrinsic chondrogenic condition depends on cell types and explore an indicator to select useful stem cells for cartilage regeneration. METHODS: The chondrogenic potential of two different stem cell types derived from adipose tissue (ASCs) and synovium (SSCs) of mice and humans was assessed using bone morphogenic protein-2 (BMP2) and transforming growth factor-β1 (TGFβ1). Their in vivo chondrogenic potential was validated through transplantation into a mouse osteochondral defect model. RESULTS: All cell types showed apparent chondrogenesis under the combination of BMP2 and TGFβ1 in vitro, as assessed by the formation of proteoglycan- and type 2 collagen (COL2)-rich tissues. However, our results vastly differed with those observed following single stimulation among species and cell types; apparent chondrogenesis of mouse SSCs was observed with supplementation of BMP2 or TGFβ1, whereas chondrogenesis of mouse ASCs and human SSCs was observed with supplementation of BMP2 not TGFβ1. Human ASCs showed no obvious chondrogenesis following single stimulation. Mouse SSCs showed the formation of hyaline-like cartilage which had less fibrous components (COL1/3) with supplementation of TGFβ1. However, human cells developed COL1/3+ tissues with all treatments. Transcriptomic analysis for TGFβ receptors and ligands of cells prior to chondrogenic induction did not indicate their distinct reactivity to the TGFβ1 or BMP2. In the transplanted site in vivo, mouse SSCs formed hyaline-like cartilage (proteoglycan+/COL2+/COL1−/COL3−) but other cell types mainly formed COL1/3-positive fibrous tissues in line with in vitro reactivity to TGFβ1. CONCLUSION: Optimal chondrogenic factors driving chondrogenesis from somatic stem cells are intrinsically distinct among cell types and species. Among them, the response to TGFβ1 may possibly represent the fate of stem cells when locally transplanted into cartilage defects. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-021-02485-5.
format Online
Article
Text
id pubmed-8281654
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82816542021-07-16 Divergence in chondrogenic potential between in vitro and in vivo of adipose- and synovial-stem cells from mouse and human Chijimatsu, Ryota Miwa, Satoshi Okamura, Gensuke Miyahara, Junya Tachibana, Naohiro Ishikura, Hisatoshi Higuchi, Junya Maenohara, Yuji Tsuji, Shinsaku Sameshima, Shin Takagi, Kentaro Nakazato, Keiu Kawaguchi, Kohei Yamagami, Ryota Inui, Hiroshi Taketomi, Shuji Tanaka, Sakae Saito, Taku Stem Cell Res Ther Research BACKGROUND: Somatic stem cell transplantation has been performed for cartilage injury, but the reparative mechanisms are still conflicting. The chondrogenic potential of stem cells are thought as promising features for cartilage therapy; however, the correlation between their potential for chondrogenesis in vitro and in vivo remains undefined. The purpose of this study was to investigate the intrinsic chondrogenic condition depends on cell types and explore an indicator to select useful stem cells for cartilage regeneration. METHODS: The chondrogenic potential of two different stem cell types derived from adipose tissue (ASCs) and synovium (SSCs) of mice and humans was assessed using bone morphogenic protein-2 (BMP2) and transforming growth factor-β1 (TGFβ1). Their in vivo chondrogenic potential was validated through transplantation into a mouse osteochondral defect model. RESULTS: All cell types showed apparent chondrogenesis under the combination of BMP2 and TGFβ1 in vitro, as assessed by the formation of proteoglycan- and type 2 collagen (COL2)-rich tissues. However, our results vastly differed with those observed following single stimulation among species and cell types; apparent chondrogenesis of mouse SSCs was observed with supplementation of BMP2 or TGFβ1, whereas chondrogenesis of mouse ASCs and human SSCs was observed with supplementation of BMP2 not TGFβ1. Human ASCs showed no obvious chondrogenesis following single stimulation. Mouse SSCs showed the formation of hyaline-like cartilage which had less fibrous components (COL1/3) with supplementation of TGFβ1. However, human cells developed COL1/3+ tissues with all treatments. Transcriptomic analysis for TGFβ receptors and ligands of cells prior to chondrogenic induction did not indicate their distinct reactivity to the TGFβ1 or BMP2. In the transplanted site in vivo, mouse SSCs formed hyaline-like cartilage (proteoglycan+/COL2+/COL1−/COL3−) but other cell types mainly formed COL1/3-positive fibrous tissues in line with in vitro reactivity to TGFβ1. CONCLUSION: Optimal chondrogenic factors driving chondrogenesis from somatic stem cells are intrinsically distinct among cell types and species. Among them, the response to TGFβ1 may possibly represent the fate of stem cells when locally transplanted into cartilage defects. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13287-021-02485-5. BioMed Central 2021-07-15 /pmc/articles/PMC8281654/ /pubmed/34266496 http://dx.doi.org/10.1186/s13287-021-02485-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chijimatsu, Ryota
Miwa, Satoshi
Okamura, Gensuke
Miyahara, Junya
Tachibana, Naohiro
Ishikura, Hisatoshi
Higuchi, Junya
Maenohara, Yuji
Tsuji, Shinsaku
Sameshima, Shin
Takagi, Kentaro
Nakazato, Keiu
Kawaguchi, Kohei
Yamagami, Ryota
Inui, Hiroshi
Taketomi, Shuji
Tanaka, Sakae
Saito, Taku
Divergence in chondrogenic potential between in vitro and in vivo of adipose- and synovial-stem cells from mouse and human
title Divergence in chondrogenic potential between in vitro and in vivo of adipose- and synovial-stem cells from mouse and human
title_full Divergence in chondrogenic potential between in vitro and in vivo of adipose- and synovial-stem cells from mouse and human
title_fullStr Divergence in chondrogenic potential between in vitro and in vivo of adipose- and synovial-stem cells from mouse and human
title_full_unstemmed Divergence in chondrogenic potential between in vitro and in vivo of adipose- and synovial-stem cells from mouse and human
title_short Divergence in chondrogenic potential between in vitro and in vivo of adipose- and synovial-stem cells from mouse and human
title_sort divergence in chondrogenic potential between in vitro and in vivo of adipose- and synovial-stem cells from mouse and human
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281654/
https://www.ncbi.nlm.nih.gov/pubmed/34266496
http://dx.doi.org/10.1186/s13287-021-02485-5
work_keys_str_mv AT chijimatsuryota divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT miwasatoshi divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT okamuragensuke divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT miyaharajunya divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT tachibananaohiro divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT ishikurahisatoshi divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT higuchijunya divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT maenoharayuji divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT tsujishinsaku divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT sameshimashin divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT takagikentaro divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT nakazatokeiu divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT kawaguchikohei divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT yamagamiryota divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT inuihiroshi divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT taketomishuji divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT tanakasakae divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman
AT saitotaku divergenceinchondrogenicpotentialbetweeninvitroandinvivoofadiposeandsynovialstemcellsfrommouseandhuman